(MedPage Today) — The FDA cleared a prescription smartphone app, dubbed LumosityRx, to help improve attention in adults with attention deficit-hyperactivity disorder (ADHD), maker Lumos Labs announced.
Teva Pharmaceutical submitted its once-monthly…
Physicians want N.L. to hit pause on a mandatory, province-wide electronic health information system
Doctors in Newfoundland and Labrador says quick implementation of a province-wide electronic health information system threatens to harm patients and...






